Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and ...

“We are pleased to welcome Darcy and Emily to Fortis,” said Dave King, CEO of Fortis Life Sciences. “Their exceptional leadership, strategic insight, and extensive industry expertise will further ...

Brenner, who has worked in the FDA’s Center for Devices and Radiological Health, will lead the agency until a permanent ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...

Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...

The Senate Finance Committee will meet on Jan. 29 to discuss the confirmation of RFK Jr., whose stances on vaccines and ...

The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the ...

CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...